Pulse Biosciences, Inc.
PLSE
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company wasā¦ read more
Healthcare
Medical Instruments & Supplies
9 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$15.46
Price-1.72%
-$0.27
1Y
Price
Market Cap
$1.048b
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow MarginRevenue
$1.664m
-
1y CAGR-33.3%
3y CAGR-37.7%
5y CAGREarnings
-$68.028m
-27.0%
1y CAGR-8.7%
3y CAGR-4.5%
5y CAGREPS
-$1.07
-16.3%
1y CAGR+9.3%
3y CAGR+13.1%
5y CAGRBook Value
$104.487m
$120.251m
Assets$15.764m
Liabilities$8.245m
DebtDebt to Assets
6.9%
-0.1x
Debt to EBITDAFree Cash Flow
-$44.735m
-22.7%
1y CAGR-0.9%
3y CAGR+2.6%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company